| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Galectin Therapeutics Inc. (GALT) have been net sellers, shedding 98,287 shares worth roughly $496K on balance. In the past 30 days, 0 insiders bought and 1 sold. Sales set the recent tone.
On the other side, 1 insider reduced a position over the period. GALT sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 5.61M | $19.37M | - | |
| CFO | 100.0K | $345.0K | - | |
| CEO | 100.0K | $345.0K | - | |
| Dir | 60.0K | $207.0K | - | |
| Dir | 60.0K | $207.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 19, 2023 | Eldred Kary81 | Director | Buy | 1,598 | $1.79 | $2,854.03 | +3.4% | +22.8% | +46.8% | |
| Feb 21, 2023 | Eldred Kary81 | Director | Buy | 1,000 | $1.59 | $1,591.10 | +2.2% | +13.7% | +16.3% | |
| Feb 16, 2023 | Lewis Joel59 | President And CEO | Buy | 1,000 | $1.52 | $1,520.00 | New | +11.3% | +16.0% | |
| Jan 25, 2023 | Eldred Kary81 | Director | Buy | 1,300 | $1.11 | $1,443.00 | +2.9% | +59.1% | +62.7% | |
| Nov 17, 2022 | Callicutt Jack W62 | Chief Financial Officer | Buy | 4,000 | $1.32 | $5,280.00 | +110.7% | +5.9% | +44.1% | |
| Oct 28, 2022 | Freeman Kevin D57 | Director | Buy | 10,000 | $1.41 | $14,100.00 | +15.4% | -20.1% | +43.2% | |
| Jul 28, 2022 | Zordani Richard A. Jr.52 | Director | Buy | 5,000 | $2.50 | $12,500.00 | +20.3% | -42.3% | -39.9% | |
| Jul 22, 2022 | 10x Fund, L.P.85 | 10% Owner | Sell | 10,000 | $2.09 | $20,870.00 | -0.2% | -15.1% | -11.9% | |
| May 19, 2022 | Freeman Kevin D57 | Director | Buy | 5,000 | $1.33 | $6,649.50 | +8.3% | +59.1% | +32.6% | |
| Apr 18, 2022 | Freeman Kevin D57 | Director | Buy | 5,000 | $1.71 | $8,550.00 | +9.1% | -3.6% | +17.9% |